Genomics announces next stage of global roll-out of its predictive clinical tool Health Insights - the first ever UKCA-marked and MHRA registered test that combines genetic and clinical factors to predict and prevent common diseases

Genomics United Kingdom England United States of America

Health Insights UK is Genomics' predictive clinical tool. It provides genetic risk testing as a secure, end-to-end solution based on a saliva sample that can be collected at home. The test provides doctors with their patient's integrated risk scores, which combine the genetic component of risk and relevant clinical risk factors, enabling healthcare professionals to make better informed decisions and to give tailored advice to their patients. View original content:https://www.prnewswire.co.uk/news-releases/genomics-announces-next-stage-of-global-roll-out-of-its-predictive-clinical-tool-health-insights---the-first-ever-ukca-marked-and-mhra-registered-test-that-combines-genetic-and-clinical-factors-to-predict-and-prevent-common-diseas-302482875.html